almost significantlyp = 0.06
22.7% of LOEU-MCI patients ( p = 0.16), and an A-/T+/N+ status was almost significantly restricted to NE-MCI patients (14.3% vs. 0% in LOEU-MCI, p = 0.06) ( Table 4 ).
22.7% of LOEU-MCI patients ( p = 0.16), and an A-/T+/N+ status was almost significantly restricted to NE-MCI patients (14.3% vs. 0% in LOEU-MCI, p = 0.06) ( Table 4 ).
On the contrary, single-domain MCI had marginally significant lower prevalence in the LOEU-MCI group than in the NE-MCI group ( n = 7, 25.9% vs. n = 11, 52.4%, p = 0.07).